Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Ownership  |  Insiders

Stock Quote Today & Recent News Launch One Acquisition Corp LPAA

Alternate Symbol(s):  LPAAW | LPAAU

Industrials Conglomerates
Launch One Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It has not selected any business combination target and the Company has not, nor has anyone on its behalf, engaged in any substantive... see more

Current News (NDAQ:LPAA)

Minovia Therapeutics Receives FDA Orphan Drug Designation for MNV-201 in Myelodysplastic Syndrome

GlobeNewswire October 15, 2025

Minovia Therapeutics Receives FDA Fast Track Designation for MNV-201 in Myelodysplastic Syndrome

GlobeNewswire September 18, 2025

Minovia Therapeutics Announces $350,000 Grant from Countdown for a Cure Foundation to Develop Mitochondria Blood-Based Biomarkers

GlobeNewswire August 27, 2025

Minovia Therapeutics Announces Interim Data from Phase 2 Trial in Pearson Syndrome Demonstrating No Treatment-Related Serious Adverse Events and Preliminary Signal for Efficacy Measured by Growth

GlobeNewswire July 24, 2025

$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger: ATMCR, CRTAF, LPAA, and AFJKU

PR Newswire July 3, 2025

$HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of Launch One Acquisition Corp. (NASDAQ: LPAA)

GlobeNewswire July 2, 2025

Minovia Therapeutics Announces FDA Fast Track and Rare Pediatric Disease Designations for MNV-201 in Pearson Syndrome

GlobeNewswire June 30, 2025

Minovia Therapeutics Ltd. and Launch One Acquisition Corp. Announce Proposed Business Combination to Create Nasdaq-Listed Mitochondrial Therapy Company in $1 Trillion+ Mitochondrial and Longevity Markets

GlobeNewswire June 25, 2025

Launch One Acquisition Corp. I Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing September 3, 2024

GlobeNewswire August 29, 2024
View More News ››

Opinion & Analysis (NDAQ:LPAA)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:LPAA)

Be the first to post on this bullboard.

Cielo Waste Solutions Corp.

Cielo Waste Solutions Corp.

Cielo Waste Solutions Corp. is a Canada-based waste-to-fuel environmental technology company. The Company is focused on ...
View More »